NYSE: ACHAccendra Health Revenue
Accendra Health revenue was $6.71B for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $697.3M, up 2.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ACH annual revenue was $10.7B, with 3.6% growth year-over-year.
ACH past revenue growth
How has ACH's revenue growth performed historically?
Company
1.38%
Industry
13.17%
Market
77.23%
ACH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ACH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ACH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
ACH revenue history
Current Revenue
$6.7B
Current Earnings
-$1.3B
Current Profit Margin
-20%
Be the first to know when ACH announces revenue.
ACH Revenue History By Year
| ACH Yearly Revenue | ACH Revenue | ACH Change | ACH Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $10.70B | $366.92M | +3.55% |
| 2023-12-31 | $10.33B | $378.49M | +3.80% |
| 2022-12-31 | $9.96B | $170.16M | +1.74% |
| 2021-12-31 | $9.79B | $1.31B | +15.39% |
| 2020-12-31 | $8.48B | -$730.76M | -7.93% |
| 2019-12-31 | $9.21B | -$207.25M | -2.20% |
| 2018-12-31 | $9.42B | $99.92M | +1.07% |
| 2017-12-31 | $9.32B | -$405.16M | -4.17% |
| 2016-12-31 | $9.72B | -$49.52M | -0.51% |
| 2015-12-31 | $9.77B | $332.76M | +3.52% |
| 2014-12-31 | $9.44B | $368.65M | +4.06% |
| 2013-12-31 | $9.07B | $203.21M | +2.29% |
| 2012-12-31 | $8.87B | $240.41M | +2.79% |
| 2011-12-31 | $8.63B | $504.30M | +6.21% |
| 2010-12-31 | $8.12B | $85.98M | +1.07% |
| 2009-12-31 | $8.04B | $794.39M | +10.97% |
| 2008-12-31 | $7.24B | $548.64M | +8.20% |
| 2007-12-31 | $6.69B | $1.25B | +23.03% |
| 2006-12-31 | $5.44B | $618.85M | +12.83% |
| 2005-12-31 | $4.82B | $297.31M | +6.57% |
| 2004-12-31 | $4.53B | $281.04M | +6.62% |
| 2003-12-31 | $4.24B | $284.29M | +7.18% |
| 2002-12-31 | $3.96B | $144.79M | +3.80% |
| 2001-12-31 | $3.81B | $311.41M | +8.89% |
| 2000-12-31 | $3.50B | $309.45M | +9.69% |
| 1999-12-31 | $3.19B | $104.09M | +3.37% |
| 1998-12-31 | $3.09B | -$26.75M | -0.86% |
| 1997-12-31 | $3.12B | $97.80M | +3.24% |
| 1996-12-31 | $3.02B | $42.52M | +1.43% |
| 1995-12-31 | $2.98B | $580.68M | +24.24% |
| 1994-12-31 | $2.40B | $998.83M | +71.50% |
| 1993-12-31 | $1.40B | $219.67M | +18.66% |
| 1992-12-31 | $1.18B | $156.28M | +15.31% |
| 1991-12-31 | $1.02B | N/A | N/A |
Accendra Health Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.